Disclosure Of Fair Value Measurement [Text Block]

Biocartis Group NV - Filing #3122955

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
114,277 EUR
142,480 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
30,284 EUR
5,843 EUR
631,722 EUR
7,502 EUR
443,363 EUR
220,302 EUR
30,284 EUR
526,405 EUR
33,897 EUR
5,572 EUR
33,897 EUR
711,874 EUR
6,862 EUR
220,657 EUR
455,343 EUR
36,824 EUR
220,657 EUR
5,153 EUR
711,874 EUR
6,102 EUR
36,824 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.